A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma ...

Artelo Biosciences Inc (NASDAQ:ARTL) shares jumped 32.9% Wednesday following the company’s announcement of a study agreement with Belfast Health and Social Care Trust to evaluate its drug candidate ...

India carries a significant share of the global glaucoma burden. Approximately 12 million people or more live with this ...

You can keep driving safely well into your later years with the right adjustments. These tips make everyday driving easier ...

SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug ...

Many dog owners initially notice only small things: The dog squints one eye, rubs its face more often, or the eye appears red ...

Vision loss exists on a wide spectrum, and low vision is very different from total blindness.

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...

Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the ...

Men are more likely to experience colour vision deficiency (colour blindness) than women, in line with the principles of Mendelian ...